William Grant

Dr. William Grant

Economics, James Madison University, Harrisonburg, Virginia, USA
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RJRavi Jhaveri
Ravi Jhaveri
WGWilliam Grant
William Grant
TKTeresa L. Kauf
Teresa L. Kauf
JMJohn McHutchison
John McHutchison

29 November 2005 in Hepatology
Verified
Journal Article
Open access
PDF file
WGWilliam Grant
William Grant
RJRavi R. Jhaveri
Ravi R. Jhaveri
JMJohn G. McHutchison
John G. McHutchison
KSKevin A. Schulman
Kevin A. Schulman
TKTeresa L. Kauf
Teresa L. Kauf
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in the United States and places tremendous demands on the health care system. As many observers have predicted, the disease burden continues to grow as the infected population ages. In this study, we analyzed inpatient data from the Healthcare Cost and Utilization Project, outpatient data from the National Ambulatory Medical Care Survey, and drug data from the Verispan Source Prescription Audit. We examined recent growth in the use of health care resources among HCV patients by age group and found average annual increases of 25% to 30% for hospitalizations, charges, hospital days, and physician visits. Corresponding time-trend coefficients were positive (P < .001). From 1994 to 2001, the HCV burden increased among patients aged 40 to 60 years, reflecting the natural history of disease progression. In sensitivity analysis, HCV outcome growth rates remained significant, unless more than 3 out of 4 cases were initially underreported. Also, patients co-infected with HIV and HCV in 2001 constituted 7.5 times as many hospitalizations and incurred 2.9 times the charges in 1994, relative to all HIV hospitalizations and charges. Our findings highlight the urgency concerning HCV outcomes. In conclusion, as patients continue to age and disease burden progresses, suboptimal decisions regarding HCV treatments will bring increasing opportunity costs for the health care system and society. (HEPATOLOGY 2005;42:1406–1413.)

13 March 2018 in The Journal of Economic Education
Verified
Journal Article
Closed access
BOBrian O'ROark
Brian O'ROark
WGWilliam Grant
William Grant
The valuable insights of game theory sometimes remain out of reach for students who are overwhelmed by the subject's complexity. Comic book applications of game theory, with superheroes as players, can facilitate enthusiasm and classroom interaction to enhance the learning of game theory. Drawing from content in superhero movies and books, the authors construct games to illustrate pure-strategy Nash equilibrium, Bayes-Nash equilibrium, mixed strategies, sub-game perfection, and perfect Bayesian equilibrium. To help instructors build students' skills in finding and interpreting game solutions, they translate comic book scenarios into specific game forms; however, not all scenarios are obvious so they suggest instructors help students develop their own game-theoretic judgments to determine what game forms, payoffs, and solution concepts might be appropriate for understanding a situation.

1 June 2008 in Journal of Economic Behavior & Organization
Verified
Journal Article
Closed access
WGWilliam Grant
William Grant
KAKevin J. Anstrom
Kevin J. Anstrom

20 May 2010 in Statistical Methods in Medical Research
Verified
Journal Article
Closed access
VBVance W Berger
Vance W Berger
WGWilliam Grant
William Grant
LVLaura F Vazquez
Laura F Vazquez
It is common, after a trial is completed, to employ sensitivity analyses to test the extent to which the results depend on various assumptions or conventions. There is a comparable benefit to employing sensitivity designs when planning a trial, so that features that cannot be varied at the analysis stage can instead be varied (e.g., across centres of a multi-centre trial) during the design stage. Design features amenable to such variation include: (1) the specific randomization methods, (2) the duration of follow-up and (3) the use or non-use of a surrogate endpoint as a replacement for a clinical endpoint. Generally, all centres in a given trial, and all trials in a given program, will employ identical protocols. This means that all will be vulnerable to the same types of biases, meaning that a single bias can by itself render all results unreliable. But by varying the randomization techniques, duration and primary endpoint, one can vary also the biases to which the site-specific results are vulnerable. This means that, if a significant result is found, then one can state that either the treatment worked or there were numerous biases (not just one) at play. This of course makes the attribution of the results to the treatments much more plausible and makes the findings much more robust to violations of assumptions.

31 December 2009 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
PDF file
MPMark E. Patterson
Mark E. Patterson
WGWilliam Grant
William Grant
SGSeth W. Glickman
Seth W. Glickman
BMBarry M. Massie
Barry M. Massie
SASusan E. Ammon
Susan E. Ammon
SRShelby D. Reed
Shelby D. Reed